Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice

Journal Title: Journal of Addiction & Prevention - Year 2014, Vol 2, Issue 2

Abstract

Methamphetamine is the second most widely used illicit drug worldwide. More than 290 tons of methamphetamine was synthesized in the year 2005 alone, corresponding to approximately ~3 billion 100 mg doses of methamphetamine. Drug addicts abuse high concentrations of methamphetamine for months and even years. Current reports in the literature are consistent with the interpretation that methamphetamine-induced neuronal injury may render methamphetamine users more susceptible to neurodegenerative pathologies. Specifically, chronic exposure to psychostimulants is associated with increases in striatal alpha-synuclein expression, a synaptic protein implicated in the pathogenesis of neurodegenerative diseases. This raises the question whether methamphetamine exposure affects alpha-synuclein levels in the brain. In this short report, we examined alpha-synuclein protein and mRNA levels in the striatum, hippocampus and cortex of adolescent male mice following a neurotoxic regimen of methamphetamine (24mg/kg/daily/14days). We found that methamphetamine exposure resulted in a decrease in the monomeric form of alpha-synuclein (molecular species 19 kDa) in the striatum and hippocampus, but not in the cortex. Despite the elevation of high molecular weight alpha-synuclein species (>19 kDa), there was no change in the alpha-synuclein mRNA levels in the striatum, hippocampus and cortex of mice exposed to methamphetamine. The methamphetamine-induced increase in high molecular weight alpha-synuclein protein levels might be one of the causal mechanisms or one of the compensatory consequences of methamphetamine-mediated neurotoxicity.

Authors and Affiliations

Habibeh Khoshbouei

Keywords

Related Articles

Mechanisms of Stimulant Drug Dependence

Objectives: Current theories of severe substance use disorder (chemical dependence) have tended to focus on either the initial phases of the process when the individual experiences WANT or on the later phases when the pr...

Player Behavioral Tracking and Personalized Feedback in Online Gambling: Implications for Prevention and Treatment of Problem Gambling

In recent years, participation in online gambling has been growing at a significant rate, as have concerns over its connection to problem gambling. The relationship between online access and problem gambling is complex....

Flexibility in Design, Outcomes and Analysis in “Evidence- Based” Drug Prevention Research: The Case of the Midwestern Prevention Project

Flexibility in study designs, definitions, outcomes and analytic models increases the chance that the results reported in an empirical study are untrue. Such flexibility in methodological and analytic practices has been...

Survey of Australian’s knowledge, Perception and Use of Cannabis for Medicinal Purposes

Objective: Changes to national and some state’s policy on the cultivation and prescription of cannabis for medicinal purposes will soon directly impact Australian medical practitioners. We investigate differences in demo...

A Factor Analysis of PTSD with Latino Samples with Substance Use Disorders

Objective: The Post - Traumatic Stress Disorder (PTSD) factor structure is not a generally agreed upon concept. It has remained controversial and its’ efficacy regarding different trauma presentations is still in questio...

Download PDF file
  • EP ID EP202557
  • DOI 10.13188/2330-2178.1000015
  • Views 112
  • Downloads 0

How To Cite

Habibeh Khoshbouei (2014). Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice. Journal of Addiction & Prevention, 2(2), 1-6. https://europub.co.uk/articles/-A-202557